CAS: 339-72-0; (S)-4-Aminoisoxazolidin-3-One

相似化合物

68-39-3 68-41-7 339-72-0

上下游产品

3-chloro-L-alanine hydroxyamide N-benzyloxycarbonyl-O-(toluene-4-sulfonyl)-L-serine benzyloxyamideN-benzyloxycarbonyl-O-(toluene-4-sulfonyl)-L-serine benzyloxyamide Methyl (2R)-2-amino-3-chloropropionate hydr°Chloride(S)-3-Oxo-4-(2-phenoxy-acetylamino)-isoxazolidine-2-sulfonatetetrabutyl-ammonium; (S)-N-(3-oxoisoxazolidin-4-yl)benzenesulfonamide 4-(4-bromo-benzylideneamino)-isoxazolidin-3-one

(S)-4-Aminoisoxazolidin-3-One (2S,3S)-2,3-Dihydroxysuccinate置于amberlite Ir-120 Plus Ion Exchange Resin (Sodium Form)体系中,用 水 用作溶剂,以64%的收率获得3-氟-4-(三氟甲基)苯甲醛
参考文献:Preparation Of D-Cycloserine And 13C-Labeled D-Cycloserine
标题:Preparation Of D-Cycloserine And 13C-Labeled D-Cycloserine
摘要:D-Cycloserine (Dcs),A Second Stage Drug For The Treatment Of Tuberculosis,Is Synthesized In 19.8% Overall Yield From Dl-Serine Methyl Ester. This Synthetic Route Gives Both Enantiomers Of Cycloserine Via A Corrected And Improved One Pot Resolution Procedure Using D-And L-Tartaric Acids. The Route Is Used To Synthesize A C-13-Labeled Derivative For Use In Biological Studies.
Doi:10.3987/com-12-12553

专利信息

专利号:US-9353057-B2
优先权日:2003-12-30
标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
发明人：GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
权利人:XENOPORT INC
摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

专利号:US-7323575-B2
优先权日:2003-04-09
标题:Process for the synthesis of (2S)-indoline-2-carboxylic acid
发明人：SOUVIE JEAN-CLAUDE; LECOUVE JEAN-PIERRE
权利人:SERVIER LAB
摘要:Process for the synthesis of (2S)-indoline-2-carboxylic acid of formula (I): n nApplication in the synthesis of perindopril and its pharmaceutically acceptable salts.

专利号:US-2024197774-A1
优先权日:2021-04-16
标 题:Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles
发明人：LOPEZ-RIBOT JOSE; VAZQUEZ-MUNOZ ROBERTO
权利人:UNIV TEXAS
摘要:Described herein is a facile, fast, and economical method for the synthesis of BAL-mediated PVP-BiNPs, using basic laboratory instruments and reagents readily available in most laboratories.

专利号:US-9255255-B2
优先权日:2013-03-04
标 题 :Synthesis of linear and branched polymers of polypeptides through direct conjugation
发明人：ALBAYRAK CEM; SWARTZ JAMES R; LU YUAN
权利人:UNIV LELAND STANFORD JUNIOR
摘要:Methods are provided for a one step synthesis of polypeptide polymers or co-polymers. The polymers or co-polymers can be linear or branched. In the methods of the invention, the coding sequence for the polypeptide(s) to be polymerized is altered by introducing one or more codons for an nonnatural amino acid, which coding sequence is then utilized to produce the cognate polypeptide. The nonnatural amino acids are selected to be reactive with each other in a bioorthogonal reaction, and are combined in a conjugation reaction with the desired components of the polymer.

专利号:US-9315483-B2
优先权日:2007-09-13
标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof
发明人：JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT
权利人:CONCERT PHARMACEUTICALS INC
摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.

专利号:US-2011087037-A1
优先权日:2007-10-31
标题:Synthesis of ring b abeo-sterols as novel inhibitors of mycobacterium tuberculosis
发明人：RODRIGUEZ-PIERLUISSI ABIMAEL D; WEI XIAOMEI
权利人:INTELLECTUAL PROPERTY AND TECHNOLOGY VIC OFF OF
摘要:Novel 3β-hydroxy-Δ 5 -steroid analogs possessing a contracted cyclopentane B-ring provide good inhibitory activity against Mycobacterium tuberculosis . The 5(6→7)abeo-sterol nucleus present in compounds of the invention represents a novel scaffold for the development of new antitubercular agents.